Zheng Y Y - OmicsDI

Show results for

Unknown (36923)
Proteomics (719)
Transcriptomics (188)
Metabolomics (92)
Genomics (41)
Models (4)
Multiomics (3)
Other (1)

Organisms

Homo sapiens (464)
Mus musculus (192)
Arabidopsis thaliana (23)
Triticum aestivum (11)
Solanum lycopersicum (7)
Caenorhabditis elegans (6)
Zea mays (6)
Drosophila melanogaster (6)
cellular organisms (4)
Macaca mulatta (3)
Oryza sativa Japonica Group (3)
Capra hircus (3)
Manihot esculenta (2)
Urocitellus parryii (2)
Streptococcus suis 05ZYH33 (2)
Streptococcus suis (2)
Spalax carmeli (1)
Nannospalax galili (1)
Lagenaria siceraria (1)
Beauveria bassiana (1)
Cicer arietinum (1)
Neurospora crassa OR74A (1)
Taenia multiceps (1)
Cordyceps militaris (1)
Rosa hybrid cultivar (1)
Paeonia ostii (1)
Dirofilaria immitis (1)
Zea mays subsp. mays (1)
Bacillus thuringiensis (1)
Pan troglodytes (1)

Organisms

Escherichia coli str. K-12 substr. MG1655 (1)
Homo sapiens (1)
Mus musculus (1)

Repository

pride (422)
iProX (267)
biostudies-arrayexpress (206)
MetaboLights (90)
MassIVE (19)
EGA (17)
jPOST (7)
BioModels (4)
ENA (4)
PeptideAtlas (3)
GNPS (2)
geo (1)
GPMDB (1)
NODE (1)
PanoramaPublic (1)

Tissue

Cell culture (117)
Epithelial cell (36)
Lung (17)
Blood plasma (16)
Leaf (16)
Permanent cell line cell (14)
Brain (13)
Liver (12)
Testis (11)
Whole body (11)
Heart (9)
Colon (8)
Fibroblast (8)
Stem cell (8)
Early embryonic cell (7)
Hepatocyte (7)
Kidney (7)
Blood (6)
Blood serum (5)
Embryonic stem cell (5)
Root (5)
Sperm (5)
Blood cell (4)
Plant cell (4)
Skin (4)
Spleen (4)
Urine (4)
Others (3)
Bone marrow (3)
Olfactory bulb (1)

Disease

Disease free (14)
Breast cancer (11)
Colon cancer (11)
Malignant neoplasm of ovary (6)
Cervix carcinoma (4)
Prostate adenocarcinoma (4)
Acute leukemia (3)
Acute kidney tubular necrosis (2)
Adult hepatocellular carcinoma (2)
Cardiovascular system disease (2)
Influenza (2)
Liver cancer (2)
Type 2 diabetes mellitus (2)
Uveal melanoma (2)
Wounds and Injuries (2)
Chronic myelogenous leukemia (1)
VSV infection (1)
Normal (1)
Not Available (1)
Alzheimer's disease (1)
Bacterial infectious disease (1)
Bladder transitional cell papilloma (1)
Bone cancer (1)
Brain cancer (1)
Bronchopulmonary dysplasia (1)
Cerebrovascular disease (1)
Cholangiocarcinoma (1)
Cognitive disorder (1)
Colorectal cancer (1)
Crohn's disease (1)

Technology Type

Mass Spectrometry (422)
Shotgun proteomics (182)
Mass spectrometry (79)
Bottom-up proteomics (74)
Data-dependent acquisition (45)
Affinity purification coupled with mass spectrometry proteomics (43)
Data-independent acquisition (36)
Gel-based experiment (31)
Top-down proteomics (18)
Chemical cross-linking coupled with mass spectrometry proteomics (11)
Mass spectrometry assay (10)
SRM/MRM (6)
SWATH MS (6)
Mass spectrometry imaging (5)
NMR spectroscopy (4)
Proteogenomics (3)
Affinity proteomics (2)
MSE (2)
Illumina Genome Analyzer II, Illumina HiSeq 2000 (1)
Illumina HiSeq 2000 (1)
Illumina HiSeq 2500 (ILLUMINA), Illumina HiSeq 4000 (ILLUMINA) (1)
HDMSE (1)
Olink affinity proteomics (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (34)
Liquid Chromatography MS - negative - reverse phase (32)
Illumina HiSeq 2000 (8)
Q Exactive HF (8)
Liquid Chromatography MS - alternating - hilic (8)
Liquid Chromatography MS - positive - hilic (7)
Liquid Chromatography MS - negative - hilic (6)
Liquid Chromatography MS - (5)
Liquid Chromatography MS - alternating - reverse phase (5)
Illumina NovaSeq 6000 (3)
LTQ Orbitrap Elite (3)
Illumina NovaSeq X (2)
TripleTOF 6600 (2)
Q Exactive (2)
Q Exactive Plus (2)
MA900, Sony (1)
10x Chromium Controller (1)
10X Chromium Controller (1)
454 GS FLX (1)
Illumina Genome Analyzer IIx (1)
Illumina Genome Analyzer II (1)
HiSeq X Ten (1)
Illumina HiSeq 2500 (1)
Instrument (1)
LTQ Orbitrap Velos (1)
Orbitrap Elite mass spectrometer(Thermo) (1)
Orbitrap Fusion (1)
Orbitrap Fusion Lumos (1)
Orbitrap Fusion Lumos ETD (Thermo Scientific instrument model) (1)
Q Exactive mass spectrometer (Thermo Scientific) (1)

Publication Date

2025 (137)
2023 (118)
2024 (113)
2026 (106)
2022 (104)
2021 (87)
2020 (62)
2014 (47)
2019 (45)
2013 (32)
2012 (27)
2018 (24)
2015 (23)
2011 (23)
2010 (23)
2017 (20)
2016 (12)
2009 (9)
2008 (4)
2007 (2)
2006 (2)
2005 (1)
2004 (1)

UNIPROT ID/AC

A0A024R563 (3)
A0A024R8H9 (3)
A0A024RAN2 (3)
A0A024RC46 (3)
A0A087WUD1 (3)
A0A087WVZ5 (3)
A0A087WWK8 (3)
A0A087WXI0 (3)
A0A087WZE9 (3)
O14543 (2)
O15524 (2)
O60674 (2)
P01112 (2)
P01579 (2)
P04049 (2)
P05231 (2)
P08887 (2)
P15260 (2)
P17676 (2)
P23458 (2)
P28482 (2)
P40189 (2)
P40763 (2)
P42224 (2)
P62136 (2)
P62993 (2)
P67775 (2)
Q02750 (2)
Q06124 (2)
Q07889 (2)

ENSEMBL ID

ENSG00000147251 (3)
ENSG00000170477 (3)
ENSG00000247315 (3)

CHEBI ID

CHEBI:15891 (31)
CHEBI:17368 (31)
CHEBI:16704 (28)
CHEBI:16708 (26)
CHEBI:17596 (26)
CHEBI:16335 (25)
CHEBI:17750 (24)
CHEBI:30769 (24)
CHEBI:15741 (23)
CHEBI:16737 (23)
CHEBI:17154 (23)
CHEBI:16750 (22)
CHEBI:17015 (22)
CHEBI:30915 (22)
CHEBI:32816 (22)
CHEBI:15428 (21)
CHEBI:15756 (21)
CHEBI:16027 (21)
CHEBI:16235 (21)
CHEBI:16919 (21)
CHEBI:17568 (21)
CHEBI:18132 (21)
CHEBI:16856 (20)
CHEBI:17295 (20)
CHEBI:17351 (20)
CHEBI:17562 (20)
CHEBI:7916 (20)
CHEBI:15971 (19)
CHEBI:16040 (19)
CHEBI:22984 (1)

Metabolite Name

Hypoxanthine (19)
Adenine (17)
Inosine (17)
Taurine (17)
Adenosine (15)
Cytidine (15)
Riboflavin (15)
Uridine (15)
Xanthine (15)
Creatine (14)
Guanine (14)
Guanosine (14)
Indole (13)
Creatinine (12)
Cytosine (12)
L-Arginine (12)
L-Palmitoylcarnitine (12)
L-Phenylalanine (12)
Betaine (11)
Carnosine (11)
Glutathione (11)
Glycerophosphocholine (11)
Glycine (11)
L-Carnitine (11)
L-Histidine (11)
L-Tryptophan (11)
Uracil (11)
Citric acid (10)
L-Glutamine (10)
L-Proline (10)

First Public Date

2014 (2)
2022 (1)
2017 (1)

Modelling Approach

Ordinary differential equation model (4)

Lab affiliation

Merck (6)
Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University (4)
Tsinghua University, China (4)
BGI Research (3)
Chair of Proteomics and Bioanalytics, Technische Universitaet Muenchen (3)
Huazhong Agricultural University (3)
Institute of Marine Sciences and Guangdong Provincial Key Laboratory of Marine Biotechnology, Shantou University, Shantou 515063, China (3)
West China Hospital, Sichuan University (3)
CAS Key Laboratory of Separation Sciences for Analytical Chemistry, National Chromatographic R&A Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences (CAS), Dalian 116023, China (2)
China Agricultural University (2)
China Agricultural University, College of Animal Science and Technolgoy, Animal genetics and breeding (2)
Department of Analytical Chemistry and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences (2)
Department of Biochemistry and Structural Biology and Center for Innovative Drug Discovery School of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78229, United States (2)
Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, United States (2)
Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center (2)
Department of Physiology & Biophysics, University of California, Irvine, Irvine, California, USA (2)
Department of Thoracic Surgery, First Affiliated Hospital of Kunming Medical University, Kunming 650000, Yunnan, China. (2)
Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China (2)
Department of Urology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China (2)
George Washington University (2)
Howard Hughes Medical Institute Beth Israel Deaconess Medical Center Harvard Medical School (2)
Hu Nan (2)
Lab of Jie Zheng, Neuroscience Research Institute and Department of Neurobiology, School of Basic Medical Sciences, Peking University, Beijing 100083, P.R. China (2)
Penn State College of Medicine, Hershey, PA, USA (2)
Professor and Chair of Chemical Biology, Peking-Tsinghua Center for Life Sciences Peking University, Beijing, China. Associate Editor, ACS Chemical Biology (2)
Professor and Chair of Chemical Biology, Peking-Tsinghua Center for Life Sciences Peking University, Beijing, China. Executive Editor, ACS Chemical Biology (2)
School of Life Science and Technology ShanghaiTech University 100 Haike Road, Shanghai, China (2)
Shandong University (2)
Shanghai Institute of Materia Medica, Chinese Academy of Sciences (2)
Shanghai Tenth People's Hospital, Tongji University School of Medicine (2)

IsPrivate

False (4)

Classification

bacteria (1)

Modification

N6 (3)
-17.026549 (1)
15.994915 (1)
2x(15)N labeled L-lysine (1)
4-tetrahydrothiazine-3-carboxylic acid (1)
57.021464 (1)
N6-dimethyl-L-lysine (1)

Study type

Transcription profiling by array (86)
RNA-seq of coding RNA (61)
RNA-seq of non coding RNA (15)
ChIP-seq (12)
Methylation profiling by high throughput sequencing (7)
Methylation profiling by array (5)
Transcription profiling by tiling array (4)
Other (4)
RNA-seq of coding RNA from single cells (4)
Comparative genomic hybridization by array (3)
ChIP-chip by tiling array (1)
Animal - High-throughput sequencing (1)
CLIP-seq (1)
MicroRNA profiling by array (1)
DNA-seq (1)

Release Date

2025 (6004)
2022 (5169)
2023 (4639)
2024 (4570)
2021 (3837)
2020 (2801)
2019 (2080)
2018 (1598)
2017 (1295)
2016 (1081)
2015 (939)
2026 (900)
2014 (670)
2013 (444)
2012 (329)
2011 (247)
2010 (171)
2009 (128)
2008 (84)
2007 (47)
2006 (30)
2005 (26)
2004 (16)
2001 (6)
2002 (5)
2000 (5)
2003 (3)
1998 (3)
1999 (2)

Previous page
1 / 3797
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 3797
Next page

Sort by:

Relevance

Page size

NMR based metabolomics study of Y2 receptor activation by neuropeptide Y in the SK-N-BE2 human neuroblastoma cell line

Neuropeptide Y (NPY) and its Y2 receptors (Y2R) play an important role in regulating growth of various tumors and are highly expressed in human neuroblastoma brain tumors. Cell lines derived from neuroblastoma brain tumors provide a good model to study the consequences of NPY activation of Y2R in tu...

2014-10-01 | MTBLS104 | MetaboLights

The transcriptional modulator H2AFY marks Huntington's disease activity in men and mice

To accelerate the development of disease-modifying therapeutics for Huntington’s disease (HD), a dynamic biomarker of disease activity and treatment response is critically needed. Venous cellular whole blood from 8 patients with Huntington's disease (HD) and 6 control subjects were collected in PAXg...

ORGANISM(S): Homo sapiens

2011-09-01 | E-GEOD-24250 | biostudies-arrayexpress

ZHENG-Omics Application in ZHENG Classification and Treatment: Chinese Personalized Medicine.

Not available

S-EPMC3638582 | biostudies-literature

Silver-Exchanged Zeolite Y Catalyzes a Selective Insertion of Carbenes into C-H and O-H Bonds.

Not available

S-EPMC10655197 | biostudies-literature

A comprehensive microsatellite landscape of human Y-DNA at kilobase resolution.

Not available

S-EPMC7821415 | biostudies-literature

Comprehensive analysis of three female patients with different types of X/Y translocations and literature review.